Other Therapeutic Modalities and Practices: Implications for Clinical Trials of Hospital-Acquired or Ventilator-Associated Pneumonia

Clicks: 69
ID: 269170
2010
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #876 of 1,084 articles by views in clinical infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract. Direct delivery of antimicrobial agents to the site of infection via aerosolization may represent a valid option in patients with ventilator-associate
Reference Key
jean2010clinicalother Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Chastre, Jean;Luyt, Charles-Edouard;
Journal clinical infectious diseases
Year 2010
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.